AI-generated summary
The authors reviewed 23 studies of photobiomodulation therapy in cancer treatment, following PRISMA guidelines, covering laser (14 studies) and LED (9 studies) approaches. They report that laser light induced cell death and increased chemotherapy sensitivity in lab studies, but some wavelengths gave divergent results between cell and animal models. Both modalities were reported to ease side effects such as oral mucositis, while the authors call for further well-designed studies.
- Studies included
- 23
- Who or what was studied
- Cancer cell lines, xenograft animal models, and patients receiving oncological treatment, as included in the reviewed studies
- Limits stated in the abstract
- The authors note that outcomes varied by light parameters, cancer type and experimental setting, and that long-term safety and efficacy remain to be established through well-designed studies.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The aim of the present systematic review is to evaluate the effects of different photobiomodulation therapy (PBMT) approaches in oncological treatment practices. The review follows the PRISMA guidelines. Specifically, the review is composed of laser PBMT and LED PBMT. A total of 23 studies were included, 14 investigating laser PBMT and 9 examining LED PBMT. In vitro studies demonstrated laser PBMT's potential to induce apoptosis and cytotoxicity in various cancer cell lines while enhancing sensitivity to chemotherapeutics and natural compounds. However, some studies highlighted divergent effects between in vitro (promoted proliferation) and in vivo xenograft models (slowed tumor growth) for certain laser wavelengths. LED PBMT studies showed blue light inhibited melanoma and pancreatic cancer cell growth, potentially via ROS generation, while red light raised concerns about enhancing oral cancer invasiveness. Both modalities mitigated treatment side effects like oral mucositis, xerostomia, peripheral neuropathy, and improved quality of life. While promising, the outcomes varied based on light parameters, cancer type, and experimental setting, necessitating further optimization of PBMT protocols through well-designed studies to establish long-term safety and efficacy across clinical scenarios.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Laser, Light-emitting diode, Reactive oxygen species, Systematic review, Oral mucositis, Neuropathy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.